Potential of acyclic nucleoside phosphonates in the treatment of DNA virus and retrovirus infections.

Abstract:

:The acyclic nucleoside phosphonates [HPMPC: cidofovir, Vistide; PMEA: adefovir dipivoxil, Hepsera; and PMPA: tenofovir, Viread] have proven to be effective in vitro (cell culture systems) and in vivo (animal models and clinical studies) against a wide variety of DNA virus and retrovirus infections, for example, cidofovir against herpesvirus [herpes simplex virus type 1 and 2, varicella-zoster virus, cytomegalovirus, Epstein-Barr virus, human herpesvirus type 6, 7 and 8), polyoma-, papilloma-, adeno- and poxvirus (variola virus, cowpox virus, vaccinia virus, molluscum contagiosum virus and orf) infections; adefovir against herpesvirus, hepadnavirus [human hepatitis B virus] and retrovirus [HIV type-1 and 2, simian immunodeficiency virus and feline immunodeficiency virus] infections; and tenofovir against both hepadna- and retrovirus infections. Cidofovir has been officially approved for the treatment of cytomegalovirus retinitis in AIDS patients, tenofovir disoproxil fumarate (Viread) for the treatment of HIV infections (i.e., AIDS) and adefovir dipivoxil for the treatment of chronic hepatitis B.

authors

De Clercq E

doi

10.1586/14787210.1.1.21

keywords:

subject

Has Abstract

pub_date

2003-06-01 00:00:00

pages

21-43

issue

1

eissn

1478-7210

issn

1744-8336

pii

ERI010104

journal_volume

1

pub_type

杂志文章,评审
  • Anti-inflammatory activity of ansamycins.

    abstract::Inflammation represents a complex biologic and biochemical process involving cells of the immune system and a plethora of biologic mediators in response to mechanical, chemical or infectious injuries. When mobilization of effector cells and molecules becomes excessive, the beneficial aspect of this response--to limit ...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.3.1.91

    authors: Labro MT

    更新日期:2005-02-01 00:00:00

  • Challenges with Diagnosing and Managing Sepsis in Older Adults.

    abstract::Sepsis in older adults has many challenges that affect rate of septic diagnosis, treatment, and monitoring parameters. Numerous age-related changes and comorbidities contribute to increased risk of infections in older adults, but also atypical symptomatology that delays diagnosis. Due to various pharmacokinetic/pharma...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.2016.1135052

    authors: Clifford KM,Dy-Boarman EA,Haase KK,Maxvill K,Pass SE,Alvarez CA

    更新日期:2016-01-01 00:00:00

  • Treatment options for second-stage gambiense human African trypanosomiasis.

    abstract::Treatment of second-stage gambiense human African trypanosomiasis relied on toxic arsenic-based derivatives for over 50 years. The availability and subsequent use of eflornithine, initially in monotherapy and more recently in combination with nifurtimox (NECT), has drastically improved the prognosis of treated patient...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.2014.959496

    authors: Eperon G,Balasegaram M,Potet J,Mowbray C,Valverde O,Chappuis F

    更新日期:2014-11-01 00:00:00

  • HIV and malaria interactions: where do we stand?

    abstract::Reversing the spread of HIV infection and the incidence of malaria constitute two of the Millenium Development Goals. However, despite recent achievements, both diseases still entail global heath problems. Furthermore, their overlapping geographical distribution raises concerns and challenges for potential immunologic...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/eri.11.167

    authors: González R,Ataíde R,Naniche D,Menéndez C,Mayor A

    更新日期:2012-02-01 00:00:00

  • Current status of Chagas disease chemotherapy.

    abstract::Chagas disease affects 7.7 million people and 28 million people are at risk of acquiring the disease in 15 endemic countries of Latin America. Benznidazole and nifurtimox are drugs that have been used to treat the disease. However, both drugs induce severe side effects. Treatment with benznidazole has been recommended...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/eri.11.31

    authors: Guedes PM,Silva GK,Gutierrez FR,Silva JS

    更新日期:2011-05-01 00:00:00

  • Efavirenz-based antiretroviral therapy versus nevirapine-including regimens for prevention of mother-to-child transmission of HIV option B plus in resource-limited settings: is there anything missing?

    abstract::In 2013, an estimated 1.5 million HIV-positive pregnant women gave birth, with 240,000 children worldwide acquiring HIV. More than 90% of new pediatric infections occurred in Sub-Saharan Africa. The latest WHO guidelines recommended efavirenz (EFV)-based antiretroviral therapy as the first-line regimen for prevention ...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.2016.1116383

    authors: De Nardo P,Gentilotti E,Nguhuni B,Vairo F,Chaula Z,Nicastri E,Ippolito G

    更新日期:2016-01-01 00:00:00

  • Levofloxacin for the treatment of community-acquired pneumonia.

    abstract::New respiratory fluoroquinolones (FQs), such as levofloxacin, offer many improved qualities over older agents, such as ciprofloxacin. These include retaining excellent Gram-negative bacilli activity, with improved Gram-positive activity. New FQ-like levofloxacin possesses greater bioavailabilty and a longer serum half...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.4.5.725

    authors: Lynch JP 3rd,File TM Jr,Zhanel GG

    更新日期:2006-10-01 00:00:00

  • Biological challenges of phage therapy and proposed solutions: a literature review.

    abstract::Introduction: In light of the emergence of antibiotic-resistant bacteria, phage (bacteriophage) therapy has been recognized as a potential alternative or addition to antibiotics in Western medicine for use in humans.Areas covered: This review assessed the scientific literature on phage therapy published between 1 Janu...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1080/14787210.2019.1694905

    authors: Caflisch KM,Suh GA,Patel R

    更新日期:2019-12-01 00:00:00

  • Antibiotic exposure in hospitalized pediatric patients in the United States: prevalence and length of stay.

    abstract:BACKGROUND:Hospital antibiotic use is rising. We aimed to evaluate the antibiotic-use prevalence and length of stay. METHODS:We conducted a single-center retrospective study of patients < 18-years-old admitted to general pediatric services who received ≥ 1 antibiotic over six months. Demographics, culture results and ...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章

    doi:10.1080/14787210.2020.1787833

    authors: Gourishankar A,Agbasi A,Kain C,Lin E

    更新日期:2020-11-01 00:00:00

  • What are the origins of growing microbial resistance? Both Lamarck and Darwin were right.

    abstract:INTRODUCTION:Microorganisms of clinical importance frequently develop resistance to drug therapy, now a growing problem. The experience with Mycobacterium tuberculosis is a representative example of increasing multi-drug resistance. To avoid reaching a crisis in which patients could be left without adequate treatment, ...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章

    doi:10.1080/14787210.2021.1839418

    authors: Guevara Salazar JA,Morán Díaz JR,Ramírez Segura E,Trujillo Ferrara JG

    更新日期:2020-10-26 00:00:00

  • Treatment of neurocysticercosis: is it beneficial?

    abstract::Neurocysticercosis is the most common parasitic disease of the CNS. Intracranial neurocysticercosis is classified into cerebral parenchymal and extraparenchymal forms (subarachnoidal and intraventricular). Current medical therapy for parenchymal and extraparenchymal neurocysticercosis invovles the use of anticysticerc...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章

    doi:10.1586/14787210.6.4.435

    authors: Garg RK

    更新日期:2008-08-01 00:00:00

  • Minor extended-spectrum β-lactamases.

    abstract::Over the last few decades, various extended-spectrum β-lactamases (ESBLs), which are remotely related to the classical TEM and SHV families, have emerged. Among these, CTX-M, VEB and PER variants are of particular interest due to their widespread dissemination. This article will focus on these emerging ESBLs. CTX-M wa...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/eri.10.119

    authors: Akinci E,Vahaboglu H

    更新日期:2010-11-01 00:00:00

  • Isavuconazole, a broad-spectrum triazole for the treatment of systemic fungal diseases.

    abstract::The prodrug isavuconazonium sulfate (BAL8557) is an extended-spectrum water-soluble triazole, developed for the treatment of severe invasive and life-threatening fungal diseases. Its active moiety, BAL4815, is a potent inhibitor of ergosterol biosynthesis, resulting in the disruption of fungal membrane structure and f...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.2015.990382

    authors: Seyedmousavi S,Verweij PE,Mouton JW

    更新日期:2015-01-01 00:00:00

  • Prophylaxis and treatment of infections associated with penetrating traumatic injury.

    abstract::Accidents or violence can result in penetrating trauma in the adult population. Contaminated penetrating foreign bodies introduced at the time of wounding cause infection, especially high velocity projectiles, which result in cavitation. Surgical debridement reduces potential infection; however, perioperative antibiot...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/eri.10.155

    authors: Petersen K,Waterman P

    更新日期:2011-01-01 00:00:00

  • Targeting drug tolerance in mycobacteria: a perspective from mycobacterial biofilms.

    abstract::Multidrug chemotherapy for 6-9-months is one of the primary treatments in effective control of tuberculosis, although the mechanisms underlying the persistence of its etiological agent, Mycobacterium tuberculosis, against antibiotics remain unclear. Ever-mounting evidence indicates that the survival of many environmen...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/eri.12.88

    authors: Islam MS,Richards JP,Ojha AK

    更新日期:2012-09-01 00:00:00

  • Antibiotic prophylaxis in colorectal surgery.

    abstract::Nosocomial infections are the most frequent complications observed in surgical patients. In colorectal surgery, the opening of the viscera causes the dissemination into the operative field of microorganisms originating from endogenous sources, increasing the chance of developing postoperative complications. It is repo...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.3.5.787

    authors: Rovera F,Diurni M,Dionigi G,Boni L,Ferrari A,Carcano G,Dionigi R

    更新日期:2005-10-01 00:00:00

  • Lymphogranuloma venereum among men who have sex with men. An epidemiological and clinical review.

    abstract::Lymphogranuloma venereum (LGV) is a sexually transmitted infection, previously only seen in tropical regions. This changed in 2003 when the first endemically acquired LGV cases were reported in Rotterdam, the Netherlands, among predominantly HIV positive men who have sex with men (MSM). Early diagnosis is important to...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.2014.901169

    authors: de Vrieze NH,de Vries HJ

    更新日期:2014-06-01 00:00:00

  • Prevention and treatment of viral diarrhea in pediatrics.

    abstract::Diarrhea is the second largest cause of mortality worldwide in children from the perinatal period to the age of 5 years. Rotavirus has been the most commonly identified viral cause of diarrhea in children. Norovirus is now recognized as the second most common viral pathogen. Adenovirus, astrovirus and sapovirus are th...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/eri.10.1

    authors: Anderson EJ

    更新日期:2010-02-01 00:00:00

  • MATH+ protocol for the treatment of SARS-CoV-2 infection: the scientific rationale.

    abstract:INTRODUCTION:COVID-19 disease progresses through a number of distinct phases. The management of each phase is unique and specific. The pulmonary phase of COVID-19 is characterized by an organizing pneumonia with profound immune dysregulation, activation of clotting, and a severe microvascular injury culminating in seve...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章

    doi:10.1080/14787210.2020.1808462

    authors: Marik PE,Kory P,Varon J,Iglesias J,Meduri GU

    更新日期:2020-08-18 00:00:00

  • Delivery of host cell-directed therapeutics for intracellular pathogen clearance.

    abstract::Intracellular pathogens present a major health risk because of their innate ability to evade clearance. Their location within host cells and ability to react to the host environment by mutation or transcriptional changes often enables survival mechanisms to resist standard therapies. Host-directed drugs do not target ...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.2013.845524

    authors: Collier MA,Gallovic MD,Peine KJ,Duong AD,Bachelder EM,Gunn JS,Schlesinger LS,Ainslie KM

    更新日期:2013-11-01 00:00:00

  • Evaluation and management of hepatitis B virus infection in hematopoietic stem cell transplantation: before and after transplantation.

    abstract::HBV infection remains a major global health problem and continues to be a common cause of liver-related morbidity and mortality in both immunocompetent and immunosuppressed individuals. Reactivation of HBV is a serious complication of chemotherapy/immunosuppressive therapy in patients with HBV infection. In this artic...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/eri.11.79

    authors: Idilman R,Arat M

    更新日期:2011-08-01 00:00:00

  • Mycobacterium caprae infection in humans.

    abstract::Mycobacterium caprae, a member of the Mycobacterium tuberculosis complex, causes tuberculosis (TB) in man and animals. Some features distinguish M. caprae from its epidemiological twin, Mycobacterium bovis: M. caprae is evolutionarily older, accounts for a smaller burden of zoonotic TB and is not globally distributed,...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.2014.974560

    authors: Prodinger WM,Indra A,Koksalan OK,Kilicaslan Z,Richter E

    更新日期:2014-12-01 00:00:00

  • Pharmacodynamics of antibiotics to treat multidrug-resistant Gram-positive hospital infections.

    abstract::Hospital infection due to multidrug-resistant Gram-positive bacteria may often represent a life-threatening challenge; thus, to appropriately combat them, clinicians should be confident and systematically apply several important pharmacodynamic concepts. The concept of 'correct antibiotic treatment' should include, in...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.5.2.255

    authors: Pea F,Viale P

    更新日期:2007-04-01 00:00:00

  • Itraconazole (Sporanox) in superficial and systemic fungal infections.

    abstract::Itraconazole (Sporanox) is a triazole antifungal agent with a broad activity spectrum and favorable pharmacokinetic and safety profiles. Numerous clinical trials have established the efficacy and safety of itraconazole in the treatment of superficial fungal infections. In this field, full exploitation of its pharmacok...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.1.4.531

    authors: Caputo R

    更新日期:2003-12-01 00:00:00

  • Immunological options for the treatment of tuberculosis: evaluation of novel therapeutic approaches.

    abstract::The emergence of multidrug-resistant tuberculosis strains and the coinfection with HIV, together with advances in immunology, have led to renewed interest regarding ways to exploit the immune responses against Mycobacterium tuberculosis therapeutically. Here we review the fundamentals of tuberculosis therapy in view o...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.5.3.461

    authors: Achkar JM,Casadevall A,Glatman-Freedman A

    更新日期:2007-06-01 00:00:00

  • The antibiotic pipeline: reviving research and development and speeding drugs to market.

    abstract:INTRODUCTION:The combination of growing antimicrobial resistance with a dry pipeline has resulted in infections that can no longer be treated. Specific reasons have led to companies' exit from the antibacterial space, however recent incentives are spurring interest to reinvigorate the pipeline. Areas covered: This arti...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1080/14787210.2017.1308251

    authors: Luepke KH,Mohr JF 3rd

    更新日期:2017-05-01 00:00:00

  • The epidemiology of pneumococcal carriage and infections in Malaysia.

    abstract::In Malaysia, various aspects of the epidemiology of pneumococcal carriage and disease remain largely unclear due to the lack of supporting data. Although a number of relevant studies have been documented, their individual discrete findings are not sufficient to inform experts on pneumococcal epidemiology at a national...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/eri.12.54

    authors: Le CF,Jefferies JM,Yusof MY,Sekaran SD,Clarke SC

    更新日期:2012-06-01 00:00:00

  • Syphilis incidence in men who have sex with men with human immunodeficiency virus comorbidity and the importance of integrating sexually transmitted infection prevention into HIV care.

    abstract:INTRODUCTION:Syphilis continues to be a growing epidemic among men who have sex with men (MSM), particularly for those living with the human immunodeficiency virus (HIV). In 2016, MSM accounted for 80% of primary and secondary syphilis diagnoses in men in the United States; almost half of who were also HIV-infected. Th...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1080/14787210.2018.1446828

    authors: Refugio ON,Klausner JD

    更新日期:2018-04-01 00:00:00

  • Treatment options for multidrug-resistant bacteria.

    abstract::As a consequence of antibiotic overuse and misuse, nosocomial infections caused by multidrug-resistant bacteria represent a physician's nightmare throughout the world. No newer antimicrobials active against Pseudomonas aeruginosa, the main multidrug-resistant nosocomial pathogen, are available or under investigation. ...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.4.4.601

    authors: Giamarellou H

    更新日期:2006-08-01 00:00:00

  • Boceprevir: an oral protease inhibitor for the treatment of chronic HCV infection.

    abstract::Chronic hepatitis C (CHC) virus infection affects more than 170 million people globally. The aim of treatment of CHC is to affect sustained elimination of the virus (a sustained virological response [SVR]). The success and duration of therapy with interferon is dependent on HCV genotype. The current standard of care c...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/eri.12.8

    authors: Trembling PM,Tanwar S,Dusheiko GM

    更新日期:2012-03-01 00:00:00